Critic at Large

» science publishing, public health and publishing

Most Recent

image: Defending Against Plagiarism

Defending Against Plagiarism

By | June 1, 2013

Publishers need to be proactive about detecting and deterring copied text.

5 Comments

image: Bring On the Transparency Index

Bring On the Transparency Index

By | August 1, 2012

Grading journals on how well they share information with readers will help deliver accountability to an industry that often lacks it.

6 Comments

image: Predatory Publishing

Predatory Publishing

By | August 1, 2012

Overzealous open-access advocates are creating an exploitative environment, threatening the credibility of scholarly publishing.

32 Comments

image: All’s Not Fair in Science and Publishing

All’s Not Fair in Science and Publishing

By | July 1, 2012

False credit for scientific discoveries threatens the success and pace of research.

72 Comments

image: Reading Into the Future

Reading Into the Future

By | April 1, 2012

Will traditional scientific journals follow newspapers into oblivion?

20 Comments

image: One Year On

One Year On

By | March 1, 2012

Some thoughts about the ecological fallout from Fukushima

0 Comments

image: An Evolving Science for an Evolving Time

An Evolving Science for an Evolving Time

By | January 1, 2012

Twenty-first century challenges to the public health of all the world’s populations require forward-looking commitments from epidemiologists.

12 Comments

image: Hard and Harder

Hard and Harder

By | June 5, 2011

The path to eradicating malaria in Africa involves much more than just a vaccine.

18 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham